{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:31:51Z","timestamp":1790937111462,"version":"4.1.0"},"reference-count":15,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T00:00:00Z","timestamp":1531872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec><jats:title>Background and purpose<\/jats:title><jats:p>Central nervous system (<jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content>) tuberculosis (<jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content>) accounts for over 4% of all <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> notifications in the UK and causes death or significant disability in over half of those affected. Tumour necrosis factor alpha is a critical cytokine involved in the neuropathogenesis of <jats:styled-content style=\"fixed-case\">CNS TB<\/jats:styled-content>. Thalidomide has been trialled in <jats:styled-content style=\"fixed-case\">CNS TB<\/jats:styled-content> due to its immunomodulatory and immune reconstitution effects through the inhibition of tumour necrosis factor alpha. Despite animal models demonstrating dramatic improvement in survival, studies in paediatric patients have been associated with higher levels of mortality. The effects of thalidomide have not yet been studied in adults with <jats:styled-content style=\"fixed-case\">CNS TB<\/jats:styled-content>.<\/jats:p><jats:p>This narrative case series guides clinicians through a range of <jats:styled-content style=\"fixed-case\">CNS TB<\/jats:styled-content> clinical cases seen in a large London teaching hospital, serving a region with a high incidence of TB (32 per 100 000) with 55% of <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> cases manifesting as extrapulmonary disease. We aimed to illustrate our experiences of using thalidomide to treat a range of severe <jats:styled-content style=\"fixed-case\">CNS TB<\/jats:styled-content> complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Five inpatients at The Royal London Hospital, London, <jats:styled-content style=\"fixed-case\">UK<\/jats:styled-content> treated with thalidomide in addition to standard <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> treatment are described in detail. The rationale for treatment initiation with thalidomide is explained.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The case examples are used to guide our reflections and lessons learnt regarding the use of thalidomide. Responses to treatment and functional outcomes suggest that thalidomide may be a useful adjunct to standard <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> therapy in selected adult cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The experience gained from using thalidomide in this small case series may provide evidence leading to more research into using thalidomide to treat severe <jats:styled-content style=\"fixed-case\">CNS TB<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ene.13732","type":"journal-article","created":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T11:40:27Z","timestamp":1529754027000},"page":"1345-1351","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical perspectives into the use of thalidomide for central nervous system tuberculosis"],"prefix":"10.1111","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2102-6053","authenticated-orcid":false,"given":"S.","family":"Keddie","sequence":"first","affiliation":[{"name":"Emergency Care and Acute Medicine Clinical Academic Group Neuroscience The Royal London Hospital Barts Health NHS Trust London"},{"name":"National Hospital for Neurology and Neurosurgery MRC Centre for Neuromuscular Diseases and Department of Molecular Neuroscience University College London Hospitals NHS Foundation Trust London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Bharambe","sequence":"additional","affiliation":[{"name":"The Walton Centre NHS Foundation Trust Liverpool"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jayakumar","sequence":"additional","affiliation":[{"name":"Division of Infection The Royal London Hospital Barts Health NHS Trust London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Shah","sequence":"additional","affiliation":[{"name":"Emergency Care and Acute Medicine Clinical Academic Group Neuroscience The Royal London Hospital Barts Health NHS Trust London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Emergency Care and Acute Medicine Clinical Academic Group Neuroscience The Royal London Hospital Barts Health NHS Trust London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Adams","sequence":"additional","affiliation":[{"name":"Emergency Care and Acute Medicine Clinical Academic Group Neuroscience The Royal London Hospital Barts Health NHS Trust London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gnanapavan","sequence":"additional","affiliation":[{"name":"Emergency Care and Acute Medicine Clinical Academic Group Neuroscience The Royal London Hospital Barts Health NHS Trust London"},{"name":"The Walton Centre NHS Foundation Trust Liverpool"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,7,18]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00042-07"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2014.0083"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/088307380401900402"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/08830738060210040801"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/088307380001500801"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(03)00077-X"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2014.01.006"},{"key":"e_1_2_9_9_1","first-page":"845","article-title":"Management of central nervous system tuberculosis in children: light and shade","volume":"14","author":"Buonsenso D","year":"2010","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.6.1887-1895.2002"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1086\/515327"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2009.06.011"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcq103"},{"key":"e_1_2_9_14_1","first-page":"3","article-title":"Immunologic cerebral vasculitis and extrapulmonary tuberculosis: an uncommon association","volume":"9","author":"Wang Y","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2009.07.012"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.10.5657"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fene.13732","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ene.13732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T12:46:24Z","timestamp":1694868384000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ene.13732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,18]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1111\/ene.13732"],"URL":"https:\/\/doi.org\/10.1111\/ene.13732","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,18]]},"assertion":[{"value":"2017-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}